Page last updated: 2024-10-21

phenytoin and Porphyria, Acute Intermittent

phenytoin has been researched along with Porphyria, Acute Intermittent in 2 studies

Porphyria, Acute Intermittent: An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.

Research Excerpts

ExcerptRelevanceReference
"The patient was initially treated for her abdominal pain and vomiting."1.35Drug use in porphyria: a therapeutic dilemma. ( Jimmy, B; Jose, J; Saravu, K; Shastry, BA, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jose, J1
Saravu, K1
Shastry, BA1
Jimmy, B1
GRETTER, TE1
DANNER, PK1
NIBBELINK, DW1
GREEN, D1
SAHS, AL1

Other Studies

2 other studies available for phenytoin and Porphyria, Acute Intermittent

ArticleYear
Drug use in porphyria: a therapeutic dilemma.
    Singapore medical journal, 2008, Volume: 49, Issue:10

    Topics: Abdominal Pain; Adult; Amines; Anticonvulsants; Antiemetics; Antihypertensive Agents; Chest Pain; Cy

2008
THE EFFECT OF DIPHENYLHYDANTOIN (DILANTIN) ON ACUTE INTERMITTENT PORPHYRIA.
    Transactions of the American Neurological Association, 1963, Volume: 88

    Topics: Animals; Body Fluids; Drug Therapy; Humans; Phenytoin; Porifera; Porphyria, Acute Intermittent; Porp

1963